Amedisys Inc (AMED) financial statements (2020 and earlier)

Company profile

Business Address 3854 AMERICAN WAY
BATON ROUGE, LA 70816
State of Incorp. DE
Fiscal Year End December 31
SIC 8082 - Home Health Care Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30211411201426
Cash and cash equivalents30211411201426
Receivables238255240236189195198
Prepaid expense81191181210
Other current assets813131471225
Other undisclosed current assets66      
Total current assets:351300276272224233259
Noncurrent Assets
Property, plant and equipment28303030293028
Intangible assets, net (including goodwill)723727727712374368369
Goodwill659660665650329324324
Intangible assets, net (excluding goodwill)65666263444445
Regulated entity, other noncurrent assets44444  
Other noncurrent assets55545855545351
Other undisclosed noncurrent assets10398111111324147
Total noncurrent assets:912913930913493493495
TOTAL ASSETS:1,2631,2121,2061,184717726753
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities289279279266221218214
Accounts payable31363633292530
Accrued liabilities1371271321229910196
Employee-related liabilities121116112111939287
Debt10986211
Other undisclosed current liabilities28272626   
Total current liabilities:327315313297222219214
Noncurrent Liabilities
Long-term debt and lease obligation, including:232232266304655124
Long-term debt, excluding current maturities232232267304655124
Other undisclosed long-term debt and lease obligation 0(0)0 (0)0
Liabilities, other than long-term debt6666666
Other liabilities6666666
Other undisclosed noncurrent liabilities56575756   
Total noncurrent liabilities:2942943303661261130
Total liabilities:621609643663234280344
Stockholders' equity
Stockholders' equity attributable to parent, including:640603562520482444408
Treasury stock, value(251)(251)(246)(244)(242)(241)(238)
Additional paid in capital645635623614604593585
Accumulated other comprehensive income0000000
Retained earnings2462191851511209261
Other undisclosed stockholders' equity attributable to parent0000000
Stockholders' equity attributable to noncontrolling interest1111111
Total stockholders' equity:642603563521483445409
TOTAL LIABILITIES AND EQUITY:1,2631,2121,2061,184717726753

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues    (1,228)417412
Revenue, net417412
Cost of revenue(470)(443)(443)(420)107(250)(366)
Cost of goods and services sold(296)(289)(291)(275) (250)(243)
Gross profit:(470)(443)(443)(420)(1,121)16846
Operating expenses11(4)(5)(3)10(128)(3)
Other undisclosed operating income5014954934671,148  
Operating income:42474544364043
Nonoperating income (expense)(2)(3)(0)(2)011
Other nonoperating income (expense)(0)200020
Interest and debt expense(3)(4)(4)(3)(2)(2)(2)
Other undisclosed income from continuing operations before equity method investments, income taxes15   7  
Income from continuing operations before equity method investments, income taxes:51404039423942
Other undisclosed income (loss) from continuing operations before income taxes(11)443(6)22
Income from continuing operations before income taxes:39444442374144
Income tax expense(11)(10)(10)(11)(9)(10)(11)
Net income:28343432283234
Net loss attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Net income available to common stockholders, diluted:28343431273133

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income:28343432283234
Comprehensive income:28343432283234
Comprehensive loss, net of tax, attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Comprehensive income, net of tax, attributable to parent:28343431273133

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: